Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F
Authors: Suga, J Marie | Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology | February 8, 2022 | PubMed abstract
